Prevalence and characteristics of tuberculosis in people living with HIV
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]diseaseHealth Condition 2: A15-A19- Tuberculosis
- Registration Number
- CTRI/2018/12/016519
- Lead Sponsor
- Kasturba Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients who are either newly diagnosed with HIV or previously diagnosed people living with HIV, under the care of Kasturba Hospitals
Exclusion Criteria
All pediatric HIV patients; any patient fulfilling the inclusion criteria, but who do not have CD4 counts tested in the last 6 months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of tuberculosis in PL-HIVTimepoint: At the time of seeing the patient (day 0)
- Secondary Outcome Measures
Name Time Method Practice of Isoniazid Prophylactic Therapy in PL-HIVTimepoint: 0, 3 months and 6 months